Zinc
The Quiet Mineral of Growth and Repair
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
25 human trials, about 26 studies, Cochrane zinc trials + lactation studies. The written rationale for this grade is still being prepared.
- FDA
- Regulated as a dietary supplement; an essential nutrient with an RDA
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
Zinc is essential, but the pregnancy supplementation evidence is limited: the current 2021 Cochrane review found little or no difference in preterm birth overall, with any benefit concentrated in women who are already deficient. For most well-nourished pregnant people the zinc requirement is met by diet and a standard prenatal, and zinc is not a high-value standalone add-on. Within the tolerable upper limit of 40 mg per day it is generally well tolerated; higher intakes can cause nausea, stomach upset, headache, and loss of appetite, and sustained doses of about 50 mg or more can interfere with copper absorption and lower copper status, so megadosing carries a real tradeoff. The clearer concern is deficiency, which is common in low-resource settings and in high-phytate or plant-based diets and has been linked in observational data to fetal growth restriction. Whether to supplement zinc, at what dose, and whether it is already covered by a prenatal is a question for an OB, midwife, or other qualified prenatal provider rather than something to self-direct.
Zinc is a trace mineral required for the activity of hundreds of enzymes, and it supports cell growth, immune function, wound healing, protein synthesis, and fetal development, with a pregnancy RDA of 11 mg per day rising to 12 mg in lactation. The supplementation evidence in pregnancy is limited: the current 2021 Cochrane review of 25 trials found that zinc may make little or no difference to preterm birth overall, a downgrade from an earlier edition that had reported a small reduction. The reduction that remains is concentrated in lower-income settings and in women who start out zinc-deficient, which is why WHO does not recommend routine zinc supplementation outside of research. Observational data still tie maternal zinc deficiency to fetal growth restriction, so the mineral clearly matters biologically even where routine supplementation does not clearly help well-nourished women.
Essential for growth, immunity, and healing, with a small and weakly recommended effect on preterm birth, and a real depletion problem after delivery.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidZinc supplements clearly prevent preterm birth and pregnancy complications.
ActuallyThe current 2021 Cochrane review of 25 trials found that zinc may make little or no difference to preterm birth overall (RR 0.87, confidence interval crossing no effect, low certainty), with little or no effect on low birthweight, small-for-gestational-age, stillbirth, or pre-eclampsia. An earlier reduction survives only in lower-income and zinc-deficient populations, which is why WHO does not recommend routine zinc supplementation outside research.
Often saidTaking more zinc while breastfeeding raises the zinc in my milk.
ActuallyAccording to LactMed, typical prenatal doses of 15 mg or less do not change milk zinc levels, and milk zinc declines naturally over the months after birth regardless of how much a mother takes. Milk zinc is largely defended by the body rather than driven by daily intake in well-nourished women.
Often saidZinc deficiency is rare and only a low-income-country problem.
ActuallyGlobal inadequate zinc intake is estimated at roughly 17% of the population, but it varies widely: about 4 to 7% in North America and Europe versus much higher rates across South and Southeast Asia and parts of Africa, and postpartum hypozincemia reached 79 to 92% at low-resource sites in the Women First trial. Risk depends heavily on diet, phytate intake, and setting.
Who profits, and who pushes back
Cochrane / systematic-review evidence
Zinc supplementation has a small but significant impact on reducing preterm births; however, the recommendation is weak and most other outcomes show no clear difference.
NIH Office of Dietary Supplements
Zinc is among the key nutrients in pregnancy; the RDA is 11 mg, rising to 12 mg in lactation, and intake is often below recommended levels.
Human-milk zinc researchers (NiPPeR and others)
Maternal zinc supplementation during preconception and pregnancy increases human-milk zinc concentrations, supporting infant growth and immune development.
Postpartum-nutrition clinicians
With 54 to 67% of postpartum women zinc-deficient, zinc is a priority for healing, immunity, and milk quality in the recovery period more than as a standalone prenatal.
Where the research comes from
Most of the published research on this comes from one place. 60% of it is from Postpartum deficient. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Postpartum deficient | 60% |
| Adequate | 40% |
Research published from: Global.
How we got here
Zinc deficiency as a human clinical problem was first described in the 1960s in the Middle East, when researchers working in Iran and Egypt linked short stature and delayed development in young men to low dietary zinc from unleavened bread high in phytate. That finding established zinc as an essential nutrient and opened decades of work on its role in growth and immunity, much of it centered on South Asia, the Middle East, and sub-Saharan Africa, where deficiency is most common. Pregnancy supplementation trials followed through the late 20th and early 21st centuries and produced a consistent but modest picture. Early pooled analyses suggested a small reduction in preterm birth, but as more trials accumulated and methods were re-examined, the current Cochrane reading settled on little or no difference overall, with any benefit confined to populations that were deficient to begin with. Attention has since broadened to the postpartum and lactation window, where deficiency is high in low-resource settings.
- 1960sZinc deficiency first described as a human clinical syndrome in Iran and Egypt, linking low dietary zinc to impaired growth and development
- 2001US Institute of Medicine sets the pregnancy zinc RDA at 11 mg/day, lactation at 12 mg/day, and the adult tolerable upper limit at 40 mg/day
- 2015Cochrane review (Ota et al.) reports a small reduction in preterm birth with zinc supplementation (RR 0.86), mainly in low-income populations
- 2010sWHO ELENA guidance concludes zinc reduces preterm birth primarily in low-income settings and does not recommend routine supplementation outside research
- 2021Updated Cochrane review (Carducci et al., 25 RCTs, 18,000+ women) revises the finding to little or no difference in preterm birth overall, low-certainty evidence
- 2024Women First trial reports high postpartum hypozincemia (79 to 92%) across Guatemala, India, and Pakistan despite months of supplementation
At a glance
- Pregnancy RDA
- 11 mg/day
- Lactation RDA
- 12 mg/day
- Postpartum deficient
- 54-67%
- Preterm effect
- Small, weak rec
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Zinc. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
2021 Cochrane review: zinc may make little or no difference to preterm birth (RR 0.87, 95% CI 0.74 to 1.03; 21 studies, 9851 participants; low certainty); little or no effect on low birthweight, small-for-gestational-age, or stillbirth; 25 RCTs, 18,000+ women
Cochrane plain-language summary (Carducci B et al., 2021, CD000230.pub6)
2015 Cochrane edition reported a small preterm-birth reduction (RR 0.86, 95% CI 0.76 to 0.97; 16 RCTs, 7637 women; moderate certainty), mainly in low-income settings
WHO does not recommend routine zinc supplementation in pregnancy (only within rigorous research); preterm-birth benefit is primarily in low-income settings and poor-zinc-status populations; no effect on low birthweight or pre-eclampsia
WHO ELENA review summary: moderate-quality evidence of a preterm-birth reduction among women receiving zinc, primarily in low-income settings and populations with poor underlying zinc status; overall nutrition should be prioritized
WHO ELENA review summary (zinc supplementation for improving pregnancy and infant outcome)
Pregnancy zinc RDA 11 mg/day, lactation RDA 12 mg/day, adult tolerable upper limit 40 mg/day; zinc supports enzyme activity, immune function, wound healing, protein synthesis, and growth and development; doses of 50 mg or more can interfere with copper absorption; excess causes nausea, headache, and gastric distress
NIH Office of Dietary Supplements, Zinc Health Professional Fact Sheet
Typical prenatal doses of 15 mg or less do not alter milk zinc levels; doses of 15 to 25 mg have negligible effect; milk zinc declines over the postpartum period regardless of supplementation; zinc supplementation is considered safe during breastfeeding
Postpartum hypozincemia reached 79% (Guatemala), 91% (India), and 92% (Pakistan) at three months despite months of supplementation; supplementation only modestly affected maternal zinc status
Women First Preconception Maternal Nutrition Trial (2024), PMC
Maternal zinc deficiency during pregnancy was associated with higher risk of low birthweight (adjusted RR 3.41) and small-for-gestational-age (adjusted RR 1.93) in a 3,187-woman Chinese birth cohort
China-Anhui Birth Cohort Study (maternal zinc deficiency and fetal growth restriction), PMC
Global inadequate zinc intake affects roughly 17% of the population, with regional prevalence of about 4 to 7% in North America and Europe and much higher rates in South and Southeast Asia and parts of Africa
Micronutrient deficiencies in pregnancy worldwide review, PMC